NCT05203328 Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
| NCT ID | NCT05203328 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Cooper Health System |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 198 participants |
| Start Date | 2022-02-01 |
| Primary Completion | 2026-03 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.
Eligibility Criteria
Inclusion Criteria: * age\>18 years * patient undergoing EBUS bronchoscopy with moderate conscious sedation. Exclusion Criteria: * subjects with previous nasal surgeries * subjects with oxygen saturation \<90% on room air prior to procedure * subjects who are pregnant * subjects with known facial fractures or recent facial trauma * subjects on any anticoagulation that cannot be discontinued prior to the procedure
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.